Lipofectamine 2000

The cationic lipid component helps form complexes with negatively charged DNA, RNA, or other nucleic acids. These lipid–nucleic acid complexes can associate with the negatively charged cell membrane, which supports their uptake by cultured eukaryotic cells. This charge-based interaction is central to moving genetic cargo from the surrounding medium into cells for downstream gene-expression studies.

After lipid–nucleic acid complexes associate with the cell membrane, cells take them up through endocytosis, a process in which membrane material encloses extracellular substances. The delivered cargo must then become available inside the cell to influence gene expression. Consequently, successful experiments depend not only on cell entry but also on intracellular release of the nucleic acid.

DNA can support expression from an introduced plasmid, whereas siRNA can produce targeted gene silencing. Reporter constructs instead provide measurable signals that indicate activity from a gene or pathway of interest. Selecting among these cargos determines whether the experiment tests gene gain of function, reduction of an endogenous signal, or monitoring of cellular responses.

A general workflow includes selecting the nucleic acid cargo, forming lipid–nucleic acid complexes, exposing cultured eukaryotic cells to those complexes, and evaluating the resulting cellular effect. The readout may involve expression of an introduced construct, reduction of a targeted gene product, or reporter activity. This sequence links delivery directly to the biological question under investigation.

In immunology studies, the method can introduce plasmids, siRNAs, reporters, or immune-related constructs into host cells. Researchers can then examine signaling pathways, inflammatory responses, or the cellular effects of candidate genes and therapeutics. These experiments connect controlled changes in gene expression with measurable immune-cell behavior or pathway activity in cultured systems.

The technique enables researchers to alter gene expression in host cells before assessing cellular responses relevant to infection. Introduced constructs can examine candidate immune regulators, while siRNA can test the contribution of selected host genes through gene silencing. Reporters can help monitor pathway activity, providing a controlled approach to studying how host cells respond to infection-related conditions.